Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Enteric-coated mycophenolate sodium in stable renal transplant recipients
NCT00238979Phase 4Completed
- Sponsor
- Novartis
- Start
- Jan 2003
- Primary completion
- Feb 2005
- Modality
- Small Molecules
01
Overview
A Phase 4 trial of mycophenolate sodium in renal transplant rejection (RTR), sponsored by Novartis. Started Jan 2003; status: completed.
02
Drugs
mycophenolate sodium
03
Conditions
renal transplant rejection (RTR)
Beyond the preview
Go deeper on NCT00238979.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00238979.